Wanbury Ltd.
| BSE: 524212 | Sector: Health care |
| NSE: WANBURY | ISIN Code: INE107F01022 |
| BSE 00:00 | 07 Aug | 37.35 |
1.75 (4.92%) |
OPEN
37.35 |
HIGH
37.35 |
LOW
36.50 |
| NSE 00:00 | 07 Aug | 37.85 |
1.80 (4.99%) |
OPEN
37.85 |
HIGH
37.85 |
LOW
36.00 |
| OPEN | 37.35 |
| PREVIOUS CLOSE | 35.60 |
| VOLUME | 3324 |
| 52-Week high | 37.35 |
| 52-Week low | 10.90 |
| P/E | |
| Mkt Cap.(Rs cr) | 93 |
| Buy Price | 37.35 |
| Buy Qty | 9533.00 |
| Sell Price | 37.35 |
| Sell Qty | 775.00 |
Wanbury Ltd. (WANBURY) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 525.80 | -1.20 | 541.00 | 315.20 | 126155.19 |
| Dr Reddy's Labs | 4571.25 | -0.28 | 4707.15 | 2352.00 | 75992.46 |
| Divi's Lab. | 2784.25 | 1.62 | 2815.00 | 1466.95 | 73907.92 |
| Cipla | 728.60 | -0.42 | 739.60 | 356.75 | 58747.02 |
| Aurobindo Pharma | 906.65 | -0.33 | 923.05 | 281.15 | 53120.62 |
| Torrent Pharma. | 2940.60 | -1.25 | 2997.00 | 1554.65 | 49760.83 |
| Biocon | 399.35 | -1.98 | 455.00 | 211.30 | 47922.00 |
| Cadila Health. | 390.70 | 0.72 | 411.60 | 206.45 | 39995.96 |
| Lupin | 879.40 | -6.07 | 955.85 | 505.00 | 39850.01 |
| Alkem Lab | 2980.30 | 4.06 | 3089.55 | 1682.10 | 35629.49 |
| Abbott India | 16188.60 | 0.29 | 18569.00 | 8484.00 | 34400.78 |
| Piramal Enterp. | 1464.35 | 0.08 | 2001.24 | 608.00 | 33028.41 |
| Glaxosmi. Pharma | 1485.05 | 0.41 | 1745.00 | 1046.40 | 25158.23 |
| Ipca Labs. | 1955.60 | -0.70 | 2032.90 | 844.20 | 24709.01 |
| Apollo Hospitals | 1744.45 | 2.97 | 1814.00 | 1047.45 | 24268.79 |
| Pfizer | 4382.00 | -0.20 | 5172.95 | 2797.50 | 20047.65 |
| Alembic Pharma | 1051.45 | -2.78 | 1128.00 | 436.10 | 19819.83 |
| Syngene Intl. | 471.85 | 1.23 | 504.20 | 201.65 | 18874.00 |
| Sanofi India | 8169.55 | 0.04 | 8528.45 | 5610.00 | 18814.47 |
| Dr Lal Pathlabs | 1903.05 | 2.85 | 2029.85 | 1060.00 | 15860.02 |
Quick Links for Wanbury:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
